252 related articles for article (PubMed ID: 25743594)
1. Inhibition of nucleoporin member Nup214 expression by miR-133b perturbs mitotic timing and leads to cell death.
Bhattacharjya S; Roy KS; Ganguly A; Sarkar S; Panda CK; Bhattacharyya D; Bhattacharyya NP; Roychoudhury S
Mol Cancer; 2015 Feb; 14():42. PubMed ID: 25743594
[TBL] [Abstract][Full Text] [Related]
2. miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression.
Duan FT; Qian F; Fang K; Lin KY; Wang WT; Chen YQ
Mol Cancer; 2013 Dec; 12():164. PubMed ID: 24330809
[TBL] [Abstract][Full Text] [Related]
3. Protein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133b.
Zhuang Q; Zhou T; He C; Zhang S; Qiu Y; Luo B; Zhao R; Liu H; Lin Y; Lin Z
J Exp Clin Cancer Res; 2016 Apr; 35():67. PubMed ID: 27074866
[TBL] [Abstract][Full Text] [Related]
4. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L.
Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L
Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
Liu X; Li G
Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
7. Identification of miR-133b and RB1CC1 as independent predictors for biochemical recurrence and potential therapeutic targets for prostate cancer.
Li X; Wan X; Chen H; Yang S; Liu Y; Mo W; Meng D; Du W; Huang Y; Wu H; Wang J; Li T; Li Y
Clin Cancer Res; 2014 May; 20(9):2312-25. PubMed ID: 24610824
[TBL] [Abstract][Full Text] [Related]
8. microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma.
Wu D; Pan H; Zhou Y; Zhou J; Fan Y; Qu P
Mol Med Rep; 2014 Jun; 9(6):2491-8. PubMed ID: 24714873
[TBL] [Abstract][Full Text] [Related]
9. Down-Regulation of MicroRNA-133b Suppresses Apoptosis of Lens Epithelial Cell by Up-Regulating BCL2L2 in Age-Related Cataracts.
Zhang F; Meng W; Tong B
Med Sci Monit; 2016 Nov; 22():4139-4145. PubMed ID: 27802259
[TBL] [Abstract][Full Text] [Related]
10. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8.
Li M; Tian L; Ren H; Chen X; Wang Y; Ge J; Wu S; Sun Y; Liu M; Xiao H
J Transl Med; 2015 Aug; 13():271. PubMed ID: 26286725
[TBL] [Abstract][Full Text] [Related]
12. MiR-133b acts as a tumor suppressor and negatively regulates TBPL1 in colorectal cancer cells.
Xiang KM; Li XR
Asian Pac J Cancer Prev; 2014; 15(8):3767-72. PubMed ID: 24870791
[TBL] [Abstract][Full Text] [Related]
13. miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo.
Hu G; Chen D; Li X; Yang K; Wang H; Wu W
Cancer Biol Ther; 2010 Jul; 10(2):190-7. PubMed ID: 20505319
[TBL] [Abstract][Full Text] [Related]
14. Excess of a Rassf1-targeting microRNA, miR-193a-3p, perturbs cell division fidelity.
Pruikkonen S; Kallio MJ
Br J Cancer; 2017 May; 116(11):1451-1461. PubMed ID: 28449010
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and -independent pathways.
Srivastava SK; Bhardwaj A; Arora S; Tyagi N; Singh S; Andrews J; McClellan S; Wang B; Singh AP
Br J Cancer; 2015 Aug; 113(4):660-8. PubMed ID: 26247574
[TBL] [Abstract][Full Text] [Related]
16. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
17. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
19. miR-21 increases the programmed cell death 4 gene-regulated cell proliferation in head and neck squamous carcinoma cell lines.
Sun Z; Li S; Kaufmann AM; Albers AE
Oncol Rep; 2014 Nov; 32(5):2283-9. PubMed ID: 25175929
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways.
Qin W; Dong P; Ma C; Mitchelson K; Deng T; Zhang L; Sun Y; Feng X; Ding Y; Lu X; He J; Wen H; Cheng J
Oncogene; 2012 Sep; 31(36):4067-75. PubMed ID: 22179829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
